Sen. Bill Cassidy says FDA needs to explain why it ignored Congress and expanded its oversight over clinical decision support software.
Human Drugs
3rd Eugia FDA-483 This Year So Far
FDA releases the form FDA-483 with three observations from an inspection at a Eugia Steriles drug manufacturing facility in Andhra Pradesh, India, the third FDA-483 so far issued to company facilities in 2024.